EVIDENCE, BEST PRACTICES AND RECOMMENDATIONS FOR HEPATITIS C SELF-TESTING: RESEARCH, IMPLEMENTATION AND COUNTRY ADAPTATION OF WHO GUIDANCE
28 August 2024 at 2:00 pm – 3:30 pm CET/CAT
Join us for a?webinar?hosted by the World Health Organization (WHO), Unitaid and the STAR Consortium.
In 2022, the WHO estimated that 58 million people were living with chronic hepatitis C (HCV), yet only 26% were aware of their status, and even fewer had received treatment. Despite advancements in treatment, low awareness and limited access to testing services keep many individuals undiagnosed.
Building on the HIV self-testing insights from the STAR Initiative, the WHO released guidance on HCV self-testing in 2021, highlighting key research priorities for implementation. This session will feature researchers and implementers from the STAR Hepatitis C Self-Testing Consortium, who will share findings on the feasibility, acceptability, accuracy, costs and cost-effectiveness of HCV self-testing across various settings. The discussion will also explore how these findings are influencing policy and guidance at the country level.
Join us for a 90-minute webinar to:
- Gain insights from STAR’s market development and implementation research conducted in five countries across Asia and Africa
- Provide updates on HCV self-testing guidance
- Review the product pipeline
Moderators: Sahar Bajis, World Health Organization and Karin Timmermans, Unitaid
Speakers:
- Anna Hellstrom, Unitaid
- Niklas Luhmann, World Health Organization
- Karin Hatzold, Population Services International
- Hedgar Plessy Mboussam, Association Camerounaise pour le Marketing Social
- Victor Abiola Adepoju, Jhpiego Nigeria
- Bao Vu Ngoc, PATH Vietnam
- Mohammed Majam, Ezintsha South Africa
- Saravanamurthy Sakthivel, PATH India
CLICK HERE TO REGISTER
